[HTML][HTML] Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus
Y Zhong, T Ji, D Qin, D Cheng - Journal of Medical Mycology, 2023 - Elsevier
Objective: To analyze clinical characteristics and risk factors for in-hospital mortality in
patients coinfected with P. jirovecii and Aspergillus. Methods: This study included 53 …
patients coinfected with P. jirovecii and Aspergillus. Methods: This study included 53 …
Long-term prednisone treatment causes fungal microbiota dysbiosis and alters the ecological interaction between gut mycobiome and bacteriome in rats
W Li, Y Shu, J Zhang, M Wu, G Zhu, W Huang… - Frontiers in …, 2023 - frontiersin.org
Glucocorticoids (GCs) are widely used in the treatment of immune-mediated diseases due to
their anti-inflammatory and immunosuppressive effects. Prednisone is one of the most …
their anti-inflammatory and immunosuppressive effects. Prednisone is one of the most …
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients
X Zhu, M Xie, J Fan, B Geng, G Fei, Q Zhou, H Wu… - Mycoses, 2024 - Wiley Online Library
Background Pneumocystis jirovecii pneumonia (PJP) is a common and troublesome
complication of kidney transplantation. In the era of prophylaxis, the peak incidence of PJP …
complication of kidney transplantation. In the era of prophylaxis, the peak incidence of PJP …
Impact of thrice-weekly cotrimoxazole prophylaxis on creatinine and potassium plasma levels in kidney transplant recipients
A Ardhe, A Devresse, R Crott, M De Meyer… - Journal of …, 2023 - Springer
Abstract Introduction Cotrimoxazole (CTX) 800/160 mg daily or thrice-weekly is
recommended as prophylaxis of Pneumocystis jirovecii pneumonia in kidney transplant …
recommended as prophylaxis of Pneumocystis jirovecii pneumonia in kidney transplant …
[引用][C] Wenyan Li, Yun Shu, Jing Zhang, Mengmeng Wu, Guang-hua Zhu, Wen-yan Huang, Li Shen 2* and Yulin Kang
Y Kang - 2023 - europepmc.org
Glucocorticoids (GCs) are widely used in the treatment of immune-mediated diseases and
organ transplantation due to their anti-inflammatory and immunosuppressive effects …
organ transplantation due to their anti-inflammatory and immunosuppressive effects …